Michiya Kawaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michiya Kawaguchi has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Toshihiko Masui
Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
6 shared publications - Kyoichi Takaori
Division of Hepatobiliary-Pancreatic Surgery and Transplantation, Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
5 shared publications - Shinji Uemoto
Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3 shared publications - Takayuki Anazawa
Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan
3 shared publications Asahi Sato
2 shared publications- Hideaki Okajima
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2 shared publications
Latest Publications
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S79
A 10-year outcome of pancreatic islet transplantation
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S79
A 10-year outcome of pancreatic islet transplantation
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S79
Is drainage culture useful in predicting postoperative pancreatic fistula after distal pancreatectomy?
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S79
Is drainage culture useful in predicting postoperative pancreatic fistula after distal pancreatectomy?
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S126
A Case of long survived patient with salvage surgery after chemoradiotherapy for the locally advanced unresectable pancreatic cancer
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S126
A Case of long survived patient with salvage surgery after chemoradiotherapy for the locally advanced unresectable pancreatic cancer
- 28 November 2014
- Vol. 15 (6) , 622-5
Non-functioning pancreatic neuroendocrine tumor accompanied with multiple liver metastases: remorseful case and literature review.
Pancreatic neuroendocrine tumor (P-NET) is a rare and slow-growing tumor. Unfortunately, there is no clear consensus on the role and timing of surgery for primary tumor and liver metastases, although current reports refer to liver surgery including LT for unresectable liver metastases. A thirty-nine-year-old man was diagnosed with nonfunctioning pancreatic neuroendocrine tumor (P-NET) in the pancreatic head, with multiple liver metastases. The tumor was 2.5 cm in diameter and he was asymptomatic. Small but multiple metastases were detected in the liver, and no extrahepatic metastases were observed. We initially intended to control the liver metastases before resection of the primary tumor. To begin with, transarterial chemoembolization (TACE) and transcatheter arterial infusion (TAI) were repeated. Thereafter, systemic chemotherapy and biotherapy were introduced according to follow-up assessments. Unfortunately, imaging assessment at about 10 months later revealed that liver metastases were partially enlarged, although some were successfully treated. Therefore, these therapies were switched to other regimens, and TACE/TAI, systemic chemotherapies and biotherapies were repeated. Although liver metastases seemed to be stable for a while, the primary tumor was enlarged even after therapy. At 3.5 years after initial diagnosis, the primary tumor became symptomatic (pain and jaundice). Liver metastases enlarged and massive swelling of the para-aortic lymph nodes was observed. Thereafter, palliative therapy was the main course of action. He died at 4.3 years after initial diagnosis. Our young patient could have been a candidate for initial surgery for primary tumor and might have had a chance of subsequent liver transplantation for unresectable metastases. Surgeons still face questions in deciding the best surgical scenario in patients with P-NET with liver metastases.
- 28 November 2014
- Vol. 15 (6) , 622-5
Non-functioning pancreatic neuroendocrine tumor accompanied with multiple liver metastases: remorseful case and literature review.
Pancreatic neuroendocrine tumor (P-NET) is a rare and slow-growing tumor. Unfortunately, there is no clear consensus on the role and timing of surgery for primary tumor and liver metastases, although current reports refer to liver surgery including LT for unresectable liver metastases. A thirty-nine-year-old man was diagnosed with nonfunctioning pancreatic neuroendocrine tumor (P-NET) in the pancreatic head, with multiple liver metastases. The tumor was 2.5 cm in diameter and he was asymptomatic. Small but multiple metastases were detected in the liver, and no extrahepatic metastases were observed. We initially intended to control the liver metastases before resection of the primary tumor. To begin with, transarterial chemoembolization (TACE) and transcatheter arterial infusion (TAI) were repeated. Thereafter, systemic chemotherapy and biotherapy were introduced according to follow-up assessments. Unfortunately, imaging assessment at about 10 months later revealed that liver metastases were partially enlarged, although some were successfully treated. Therefore, these therapies were switched to other regimens, and TACE/TAI, systemic chemotherapies and biotherapies were repeated. Although liver metastases seemed to be stable for a while, the primary tumor was enlarged even after therapy. At 3.5 years after initial diagnosis, the primary tumor became symptomatic (pain and jaundice). Liver metastases enlarged and massive swelling of the para-aortic lymph nodes was observed. Thereafter, palliative therapy was the main course of action. He died at 4.3 years after initial diagnosis. Our young patient could have been a candidate for initial surgery for primary tumor and might have had a chance of subsequent liver transplantation for unresectable metastases. Surgeons still face questions in deciding the best surgical scenario in patients with P-NET with liver metastases.
- 1 November 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 288 (3) , 711-717
A Novel Synthetic Arg-Gly-Asp-Containing Peptide Cyclo(-RGDfV-) Is the Potent Inhibitor of Angiogenesis
- 1 November 2001
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 288 (3) , 711-717
A Novel Synthetic Arg-Gly-Asp-Containing Peptide Cyclo(-RGDfV-) Is the Potent Inhibitor of Angiogenesis
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A290-290
Apoptosis-related proteins in human embryonic/fetal pancreas and pancreatic ductal carcinoma
- 30 April 2000
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A290-290
Apoptosis-related proteins in human embryonic/fetal pancreas and pancreatic ductal carcinoma